☰

Pamela M. McMahon, Ph.D. - Publications

Affiliations: 
2005 Harvard University, Cambridge, MA, United States 
Area:
Public Health, Statistics, Health Care Management
Tree Info Similar researchers PubMed Report error

53 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Munshi V, McMahon P. Importance of Smoking Cessation in a Lung Cancer Screening Program. Current Surgery Reports. 1. PMID 24312745 DOI: 10.1007/S40137-013-0030-1  0.402
2019 Yeh J, Stout NK, Chaudhry A, Gooch M, McMahon P, Christensen KD, Diller L, Wu AC. Population-based cancer predisposition testing as a component of newborn screening: A cost-effectiveness analysis. Journal of Clinical Oncology. 37: 10021-10021. DOI: 10.1200/Jco.2019.37.15_Suppl.10021  0.452
2017 Han SS, Ten Haaf K, Hazelton WD, Munshi VN, Jeon J, Erdogan SA, Johanson C, McMahon PM, Meza R, Kong CY, Feuer EJ, de Koning HJ, Plevritis SK. The impact of overdiagnosis on the selection of efficient lung cancer screening strategies. International Journal of Cancer. PMID 28073150 DOI: 10.1002/Ijc.30602  0.414
2016 Kong CY, Sheehan DF, McMahon PM, Gazelle GS, Pandharipande P. Combined Biomarker and Computed Tomography Screening Strategies for Lung Cancer: Projections of Health and Economic Tradeoffs in the US Population. Mdm Policy & Practice. 1. PMID 30148212 DOI: 10.1177/2381468316643968  0.567
2016 Tramontano AC, Sheehan DF, McMahon PM, Dowling EC, Holford TR, Ryczak K, Lesko SM, Levy DT, Kong CY. Evaluating the impacts of screening and smoking cessation programmes on lung cancer in a high-burden region of the USA: a simulation modelling study. Bmj Open. 6: e010227. PMID 26928026 DOI: 10.1136/Bmjopen-2015-010227  0.425
2015 Tramontano AC, Schrag DL, Malin JK, Miller MC, Weeks JC, Swan JS, McMahon PM. Catalog and comparison of societal preferences (utilities) for lung cancer health states: results from the Cancer Care Outcomes Research and Surveillance (CanCORS) study. Medical Decision Making : An International Journal of the Society For Medical Decision Making. 35: 371-87. PMID 25670839 DOI: 10.1177/0272989X15570364  0.373
2015 Lowry KP, Gazelle GS, Gilmore ME, Johanson C, Munshi V, Choi SE, Tramontano AC, Kong CY, McMahon PM. Personalizing annual lung cancer screening for patients with chronic obstructive pulmonary disease: A decision analysis. Cancer. 121: 1556-62. PMID 25652107 DOI: 10.1002/Cncr.29225  0.612
2014 Tramontano A, McMahon PM, El-Jawahri A, Parikh RB, Gallagher ER, Pirl WF, Jackson VA, Muzikansky A, Temel JS. Cost analysis of a randomized trial of early palliative care (PC) in patients with metastatic non-small cell lung cancer (NSCLC). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 32: 4. PMID 28142855 DOI: 10.1200/Jco.2014.32.31_Suppl.4  0.361
2014 Goehler A, McMahon PM, Lumish HS, Wu CC, Munshi V, Gilmore M, Chung JH, Ghoshhajra BB, Mark D, Truong QA, Gazelle GS, Hoffmann U. Cost-effectiveness of follow-up of pulmonary nodules incidentally detected on cardiac computed tomographic angiography in patients with suspected coronary artery disease. Circulation. 130: 668-75. PMID 25015342 DOI: 10.1161/Circulationaha.113.007306  0.51
2014 McMahon PM, Meza R, Plevritis SK, Black WC, Tammemagi CM, Erdogan A, ten Haaf K, Hazelton W, Holford TR, Jeon J, Clarke L, Kong CY, Choi SE, Munshi VN, Han SS, et al. Comparing benefits from many possible computed tomography lung cancer screening programs: extrapolating from the National Lung Screening Trial using comparative modeling. Plos One. 9: e99978. PMID 24979231 DOI: 10.1371/Journal.Pone.0099978  0.458
2014 Meza R, ten Haaf K, Kong CY, Erdogan A, Black WC, Tammemagi MC, Choi SE, Jeon J, Han SS, Munshi V, van Rosmalen J, Pinsky P, McMahon PM, de Koning HJ, Feuer EJ, et al. Comparative analysis of 5 lung cancer natural history and screening models that reproduce outcomes of the NLST and PLCO trials. Cancer. 120: 1713-24. PMID 24577803 DOI: 10.1002/Cncr.28623  0.458
2014 Lubitz CC, Kong CY, McMahon PM, Daniels GH, Chen Y, Economopoulos KP, Gazelle GS, Weinstein MC. Annual financial impact of well-differentiated thyroid cancer care in the United States. Cancer. 120: 1345-52. PMID 24481684 DOI: 10.1002/Cncr.28562  0.568
2014 de Koning HJ, Meza R, Plevritis SK, ten Haaf K, Munshi VN, Jeon J, Erdogan SA, Kong CY, Han SS, van Rosmalen J, Choi SE, Pinsky PF, Berrington de Gonzalez A, Berg CD, Black WC, ... ... McMahon PM, et al. Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the U.S. Preventive Services Task Force. Annals of Internal Medicine. 160: 311-20. PMID 24379002 DOI: 10.7326/M13-2316  0.486
2013 Hayes JH, Ollendorf DA, Pearson SD, Barry MJ, Kantoff PW, Lee PA, McMahon PM. Observation versus initial treatment for men with localized, low-risk prostate cancer: a cost-effectiveness analysis. Annals of Internal Medicine. 158: 853-60. PMID 23778902 DOI: 10.7326/0003-4819-158-12-201306180-00002  0.313
2013 Tramontano AC, Cipriano LE, Kong CY, Shepard JA, Lanuti M, Gazelle GS, McMahon PM. Microsimulation model predicts survival benefit of radiofrequency ablation and stereotactic body radiotherapy versus radiotherapy for treating inoperable stage I non-small cell lung cancer. Ajr. American Journal of Roentgenology. 200: 1020-7. PMID 23617484 DOI: 10.2214/Ajr.12.8968  0.54
2013 Cott Chubiz JE, Lee JM, Gilmore ME, Kong CY, Lowry KP, Halpern EF, McMahon PM, Ryan PD, Gazelle GS. Cost-effectiveness of alternating magnetic resonance imaging and digital mammography screening in BRCA1 and BRCA2 gene mutation carriers Cancer. 119: 1266-1276. PMID 23184400 DOI: 10.1002/Cncr.27864  0.56
2012 Rosenberg MA, Feuer EJ, Yu B, Sun J, Henley SJ, Shanks TG, Anderson CM, McMahon PM, Thun MJ, Burns DM. Chapter 3: Cohort life tables by smoking status, removing lung cancer as a cause of death. Risk Analysis : An Official Publication of the Society For Risk Analysis. 32: S25-38. PMID 22882890 DOI: 10.1111/J.1539-6924.2011.01662.X  0.33
2012 McMahon PM, Hazelton WD, Kimmel M, Clarke LD. Chapter 13: CISNET lung models: comparison of model assumptions and model structures. Risk Analysis : An Official Publication of the Society For Risk Analysis. 32: S166-78. PMID 22882887 DOI: 10.1111/J.1539-6924.2011.01714.X  0.399
2012 McMahon PM, Kong CY, Johnson BE, Weinstein MC, Weeks JC, Tramontano AC, Cipriano LE, Bouzan C, Gazelle GS. Chapter 9: The MGH-HMS lung cancer policy model: tobacco control versus screening. Risk Analysis : An Official Publication of the Society For Risk Analysis. 32: S117-24. PMID 22882882 DOI: 10.1111/J.1539-6924.2011.01652.X  0.61
2012 Moolgavkar SH, Holford TR, Levy DT, Kong CY, Foy M, Clarke L, Jeon J, Hazelton WD, Meza R, Schultz F, McCarthy W, Boer R, Gorlova O, Gazelle GS, Kimmel M, ... McMahon PM, et al. Impact of reduced tobacco smoking on lung cancer mortality in the United States during 1975-2000. Journal of the National Cancer Institute. 104: 541-8. PMID 22423009 DOI: 10.1093/Jnci/Djs136  0.566
2012 Kong CY, Lee JM, McMahon PM, Lowry KP, Omer ZB, Eisenberg JD, Pandharipande PV, Gazelle GS. Using radiation risk models in cancer screening simulations: important assumptions and effects on outcome projections. Radiology. 262: 977-84. PMID 22357897 DOI: 10.1148/Radiol.11110352  0.571
2012 Lowry KP, Lee JM, Kong CY, McMahon PM, Gilmore ME, Cott Chubiz JE, Pisano ED, Gatsonis C, Ryan PD, Ozanne EM, Gazelle GS. Annual screening strategies in BRCA1 and BRCA2 gene mutation carriers: a comparative effectiveness analysis. Cancer. 118: 2021-30. PMID 21935911 DOI: 10.1002/Cncr.26424  0.557
2012 Greer JA, McMahon PM, Tramontano A, Gallagher ER, Pirl WF, Jackson VA, Temel JS. Effect of early palliative care on health care costs in patients with metastatic NSCLC. Journal of Clinical Oncology. 30: 6004-6004. DOI: 10.1200/Jco.2012.30.15_Suppl.6004  0.328
2011 Kong CY, Nattinger KJ, Hayeck TJ, Omer ZB, Wang YC, Spechler SJ, McMahon PM, Gazelle GS, Hur C. The impact of obesity on the rise in esophageal adenocarcinoma incidence: estimates from a disease simulation model. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 20: 2450-6. PMID 21930957 DOI: 10.1158/1055-9965.Epi-11-0547  0.478
2011 McMahon PM, Kong CY, Bouzan C, Weinstein MC, Cipriano LE, Tramontano AC, Johnson BE, Weeks JC, Gazelle GS. Cost-effectiveness of computed tomography screening for lung cancer in the United States. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 6: 1841-8. PMID 21892105 DOI: 10.1097/Jto.0B013E31822E59B3  0.631
2011 Abujudeh HH, Kaewlai R, McMahon PM, Binder W, Novelline RA, Gazelle GS, Thrall JH. Abdominopelvic CT increases diagnostic certainty and guides management decisions: a prospective investigation of 584 patients in a large academic medical center. Ajr. American Journal of Roentgenology. 196: 238-43. PMID 21257870 DOI: 10.2214/Ajr.10.4467  0.495
2011 Cipriano LE, Romanus D, Earle CC, Neville BA, Halpern EF, Gazelle GS, McMahon PM. Lung cancer treatment costs, including patient responsibility, by disease stage and treatment modality, 1992 to 2003. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 14: 41-52. PMID 21211485 DOI: 10.1016/J.Jval.2010.10.006  0.598
2011 Goehler A, McMahon PM, Gupta S, Gilmore M, Brady TJ, Gazelle GS, Hoffmann U, Truong QA. COST-EFFECTIVENESS OF FOLLOW-UP OF INCIDENTAL LUNG NODULES DETECTED DURING CONTRAST ENHANCED CORONARY CTA IN PATIENTS WITH CHEST PAIN Journal of the American College of Cardiology. 57: E781. DOI: 10.1016/S0735-1097(11)60781-X  0.535
2011 Nattinger KJ, Kong CY, Hayeck TJ, Omer Z, Liang C, Wang YC, Spechler SJ, McMahon PM, Gazelle GS, Hur C. The Effect of Obesity on Esophageal Adenocarcinoma Gastroenterology. 140: S-357. DOI: 10.1016/S0016-5085(11)61457-1  0.468
2010 Hayes JH, Ollendorf DA, Pearson SD, Barry MJ, Kantoff PW, Stewart ST, Bhatnagar V, Sweeney CJ, Stahl JE, McMahon PM. Active surveillance compared with initial treatment for men with low-risk prostate cancer: a decision analysis. Jama. 304: 2373-80. PMID 21119084 DOI: 10.1001/Jama.2010.1720  0.33
2010 Lee JM, McMahon PM, Kong CY, Kopans DB, Ryan PD, Ozanne EM, Halpern EF, Gazelle GS. Cost-effectiveness of breast MR imaging and screen-film mammography for screening BRCA1 gene mutation carriers. Radiology. 254: 793-800. PMID 20177093 DOI: 10.1148/Radiol.09091086  0.557
2010 Hayes JH, Ollendorf DA, Barry MJ, Pearson SD, McMahon PM. Therapeutic options for low-risk prostate cancer: A cost-effectiveness analysis. Journal of Clinical Oncology. 28: 6012-6012. DOI: 10.1200/Jco.2010.28.15_Suppl.6012  0.377
2009 Kong CY, McMahon PM, Gazelle GS. Calibration of disease simulation model using an engineering approach. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 12: 521-9. PMID 19900254 DOI: 10.1111/J.1524-4733.2008.00484.X  0.512
2009 Stout NK, Knudsen AB, Kong CY, McMahon PM, Gazelle GS. Calibration methods used in cancer simulation models and suggested reporting guidelines. Pharmacoeconomics. 27: 533-45. PMID 19663525 DOI: 10.2165/11314830-000000000-00000  0.534
2008 McMahon PM, Kong CY, Weinstein MC, Tramontano AC, Cipriano LE, Johnson BE, Weeks JC, Gazelle GS. Adopting helical CT screening for lung cancer: potential health consequences during a 15-year period. Cancer. 113: 3440-9. PMID 18988293 DOI: 10.1002/Cncr.23962  0.621
2008 McMahon PM, Gazelle SG. Response to "comentary: lung cancer screening--progress or peril. The Oncologist. 13: 733. PMID 18649407 DOI: 10.1634/Theoncologist.2008-0116  0.395
2008 McMahon PM, Kong CY, Johnson BE, Weinstein MC, Weeks JC, Kuntz KM, Shepard JA, Swensen SJ, Gazelle GS. Estimating long-term effectiveness of lung cancer screening in the Mayo CT screening study. Radiology. 248: 278-87. PMID 18458247 DOI: 10.1148/Radiol.2481071446  0.603
2008 Lee JM, Kopans DB, McMahon PM, Halpern EF, Ryan PD, Weinstein MC, Gazelle GS. Breast cancer screening in BRCA1 mutation carriers: effectiveness of MR imaging--Markov Monte Carlo decision analysis. Radiology. 246: 763-71. PMID 18309013 DOI: 10.1148/Radiol.2463070224  0.551
2007 McMahon PM, Christiani DC. Computed tomography screening for lung cancer. Bmj (Clinical Research Ed.). 334: 271. PMID 17289689 DOI: 10.1136/Bmj.39090.662963.80  0.501
2007 Knudsen AB, McMahon PM, Gazelle GS. Use of modeling to evaluate the cost-effectiveness of cancer screening programs. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 25: 203-8. PMID 17210941 DOI: 10.1200/Jco.2006.07.9202  0.606
2006 McMahon PM, Zaslavsky AM, Weinstein MC, Kuntz KM, Weeks JC, Gazelle GS. Estimation of mortality rates for disease simulation models using Bayesian evidence synthesis. Medical Decision Making : An International Journal of the Society For Medical Decision Making. 26: 497-511. PMID 16997927 DOI: 10.1177/0272989X06291326  0.48
2005 Gazelle GS, McMahon PM, Siebert U, Beinfeld MT. Cost-effectiveness analysis in the assessment of diagnostic imaging technologies. Radiology. 235: 361-70. PMID 15858079 DOI: 10.1148/Radiol.2352040330  0.493
2004 Gazelle GS, McMahon PM, Beinfeld MT, Halpern EF, Weinstein MC. Metastatic colorectal carcinoma: cost-effectiveness of percutaneous radiofrequency ablation versus that of hepatic resection. Radiology. 233: 729-39. PMID 15564408 DOI: 10.1148/Radiol.2333032052  0.541
2003 McMahon PM, Araki SS, Sandberg EA, Neumann PJ, Gazelle GS. Cost-effectiveness of PET in the diagnosis of Alzheimer disease. Radiology. 228: 515-22. PMID 12802006 DOI: 10.1148/Radiol.2282020915  0.501
2003 Gazelle GS, Hunink MG, Kuntz KM, McMahon PM, Halpern EF, Beinfeld M, Lester JS, Tanabe KK, Weinstein MC. Cost-effectiveness of hepatic metastasectomy in patients with metastatic colorectal carcinoma: a state-transition Monte Carlo decision analysis. Annals of Surgery. 237: 544-55. PMID 12677152 DOI: 10.1097/01.Sla.0000059989.55280.33  0.55
2002 McMahon PM, Gazelle GS. Colorectal cancer screening issues: a role for CT colonography? Abdominal Imaging. 27: 235-43. PMID 12173353  0.579
2001 Gleason S, Furie KL, Lev MH, O'Donnell J, McMahon PM, Beinfeld MT, Halpern E, Mullins M, Harris G, Koroshetz WJ, Gazelle GS. Potential influence of acute CT on inpatient costs in patients with ischemic stroke. Academic Radiology. 8: 955-64. PMID 11699848 DOI: 10.1016/S1076-6332(03)80639-6  0.532
2001 McMahon PM, Halpern EF, Fernandez-del Castillo C, Clark JW, Gazelle GS. Pancreatic cancer: cost-effectiveness of imaging technologies for assessing resectability. Radiology. 221: 93-106. PMID 11568326 DOI: 10.1148/Radiol.2211001656  0.574
2001 Bosch JL, Lester JS, McMahon PM, Beinfeld MT, Halpern EF, Kaufman JA, Brewster DC, Gazelle GS. Hospital costs for elective endovascular and surgical repairs of infrarenal abdominal aortic aneurysms. Radiology. 220: 492-7. PMID 11477259 DOI: 10.1148/Radiology.220.2.R01Au29492  0.472
2001 McMahon PM, Bosch JL, Gleason S, Halpern EF, Lester JS, Gazelle GS. Cost-effectiveness of colorectal cancer screening. Radiology. 219: 44-50. PMID 11274533 DOI: 10.1148/Radiology.219.1.R01Ap3144  0.619
2000 McMahon PM, Scott Gazelle G. The case for colorectal cancer screening Seminars in Roentgenology. 35: 325-332. PMID 11060919 DOI: 10.1053/Sroe.2000.17753  0.469
2000 McMahon PM, Araki SS, Neumann PJ, Harris GJ, Scott Gazelle G. Cost-effectiveness of functional imaging tests in the diagnosis of Alzheimer disease Radiology. 217: 58-68. PMID 11012424 DOI: 10.1148/Radiology.217.1.R00Se1358  0.363
2000 Gazelle GS, McMahon PM, Scholz FJ. Screening for colorectal cancer Radiology. 215: 327-335. PMID 10796903 DOI: 10.1148/Radiology.215.2.R00Ma19327  0.613
Show low-probability matches.